Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Comparing the Long-term Outcomes of Coronary Artery Bypass Grafting (CABG) vs. Percutaneous Coronary Intervention
Rubela Ray1, Shivam Singla2, Ghazala S Virk3
1Bankura Sammilani Medical College, Bankura, India.
Insights
For multivessel coronary artery disease (MVD), Coronary Artery Bypass Grafting (CABG) shows better long-term survival and fewer repeat procedures than Percutaneous Coronary Intervention (PCI). However, CABG has a slightly higher stroke risk, necessitating personalized treatment choices.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Multivessel Coronary Artery Disease (MVD) is commonly treated with Coronary Artery Bypass Grafting (CABG) or Percutaneous Coronary Intervention (PCI).
- The long-term comparative effectiveness of CABG versus PCI for MVD is not well-established.
Purpose of the Study:
- To compare the long-term effectiveness of CABG and PCI in patients with MVD.
- To evaluate outcomes including mortality, repeat revascularization, and stroke.
Main Methods:
- A systematic review and meta-analysis of randomized and observational studies.
- Included patients with MVD followed for at least 5 years.
- Pooled data using random-effects or fixed-effects models based on heterogeneity.
Main Results:
- Thirteen studies were included in the analysis.
- CABG was associated with significantly lower all-cause mortality (RR 0.82) and repeat revascularizations (RR 1.98) compared to PCI.
- A slightly increased risk of stroke was observed after CABG.
Conclusions:
- CABG demonstrates superior long-term survival and reduced adverse events in MVD patients.
- The increased stroke risk with CABG necessitates individualized treatment decisions.
- PCI remains a viable option for patients with lower-risk anatomy or surgical contraindications.
Introduction:
Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) are standard treatments for Multivessel Coronary Artery Disease (MVD). Their long-term comparative effectiveness remains debated.
Method:
A systematic review and meta-analysis of randomized and observational studies was conducted, including patients with MVD followed for ≥5 years. Data were pooled using randomor fixed-effects models, depending on the level of heterogeneity.
Results:
Thirteen studies met the inclusion criteria. CABG was associated with reduced all-cause mortality (RR 0.82, 95% CI 0.72-0.91) and fewer repeat revascularizations (RR 1.98, 95% CI 1.74-2.26) compared with PCI. Stroke risk was slightly higher after CABG.
Discussion:
Findings suggest CABG provides superior survival and event reduction in long-term follow-up, particularly in higher-risk subgroups. However, the modestly increased stroke risk highlights the need for individualized decision-making, taking into account patient comorbidities, anatomy, and surgical suitability.
Conclusion:
CABG offers long-term survival and durability advantages over PCI in MVD, while PCI remains suitable for patients with lower-risk anatomy or when surgery is contraindicated.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Cardiomyopathy V: Interprofessional Care

